Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Endocrinology  |  Family Medicine

Search Medical Condition
Please enter condition
Please choose location from dropdown

Diabetes Mellitus, Type 2 Clinical Trials

A listing of Diabetes Mellitus, Type 2 medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (1072) clinical trials

You are being asked to participate in a study of a new drug, Alirocumab [“study drug”] because you have high cholesterol despite the cholesterol lowering drugs you are currently taking. The study drug is a fully human monoclonal antibody (a type of protein). The study drug is a type of ...

Phase N/A

Using a new oral medication in the same class as Invokana and Farxiga (SGLT2 inhibitors) to demonstrate similar or better efficacy with a better safety profile.

Phase

A research study is evaluating a Smartphone app for people with Type 1 or Type 2 Diabetes. This study is examining the ACCU-CHEK® Connect Diabetes Management System to learn whether this system improves treatment satisfaction in patients with type 1 and type 2 diabetes.

Phase N/A

A 52 week randomized, open-label, parallel group real world pragmatic trial to assess the clinical and health outcomes of an experimental drug compared to commercially available basal insulin’s for initiation of therapy in insulin naïve patients with uncontrolled type 2 diabetes mellitus

Phase

A randomized double blind study comparing the effect of ticagrelor versus placebo on the incidence of cardiovascular death, myocardial infarction or stroke in patients with type 2 diabetes mellitus.

Phase N/A

The study drug reduces CVS events and type 2 Diabetes mellitus in overweight patients

Phase N/A

This is a trial designed to evaluate cardiovascular outcome data.The purpose of this cardiovascular outcome trial is to confirm the cardiovascular safety of of insulin brands in subjects with type 2 diabetes at high risk for cardiovascular events.

Phase

This study will look at brain glycolysis in participants with and without type 2 diabetes. Participation will require a total of 3 outpatient visits over about 4 to 6 weeks. Each visit will last about 1 full day. Participation includes EKG, blood draw, lumbar puncture, IV insertion, MRI and PET ...

Phase N/A